Ikove Venture Partners Announces the Launch of Ulevo Health, Inc.
Ikove Venture Partners Announces the Launch of Ulevo Health, Inc., a Technology Developed by the University of Miami & The Miami Project to Cure Paralysis to Detect and Treat Muscle Spasms
February 01, 2023, Miami, FL – Ikove Venture Partners announced today that they have licensed certain technology from the University of Miami and The Miami Project to Cure Paralysis, to launch Ulevo Health, www.ulevohealth.com, a provider of medical devices which detect and stop debilitating muscle spasms due to neurological disease, paralysis, spinal injury and chronic cramping of any kind. Ulevo Health offers a wearable device that detects muscle spasms and produces a corrective stimulation as needed to immediately arrest the spasm and associated discomfort.
Today, over 1,000,000 people annually in the United States, and over 12,000,000 worldwide, suffer from a seemingly intractable problem, the discomfort, pain, and loss of sleep associated with muscle spasms. The University of Miami’s Vice Provost for Innovation and Chief Innovation Officer, Miller School of Medicine, Dr. Norma Kenyon, stated, “the University has licensed certain technology to Ikove, and they will continue to support it with funding, management and infrastructure through the commercialization process.”
For neurologists, medical providers and their patients, these devices are lightweight, personalized to the patient and worn on the ankle or above the knee to automatically detect and eliminate muscle spasms with stimulation. “We are extremely pleased to have licensed the technology from the University of Miami and The Miami Project and look forward to a long and a mutually beneficial future of continued technology development,” said Ikove Venture’s Co-Founder, Flavio Lobato, a University of Miami alumnus. “For me personally, to be back in Miami and to be able to work with technology that was developed at the University of Miami is truly an honor,” he continued.
The “standard of treatment” today, those which are even moderately effective, are pharmacological-only. There is no effective electro-mechanical solution available to treat muscle spasms and the associated discomfort, pain, loss of sleep and numerous other negative side effects. In addition, the highly undesirable side-effects of the current pharmaceutical treatments range from loss of all motor control to drowsiness, dizziness, disorientation, and addiction. “Ulevo Health’s technology will dramatically change the landscape of spasm detection, treatment, and relief,” said Jack Karabees, Ulevo Health’s Co-Founder and CEO.
About Ulevo Health
Ulevo Health, www.ulevohealth.com, provides personalized devices to automatically detect, reduce and eliminate muscle spasms with stimulation. These spasms are generally due to neurological disease, such as multiple sclerosis, brain, or spinal cord injury, but are also associated with other conditions. This patented technology is intended to alleviate the most disabling aspect of spasticity, the involuntary muscle contractions that occur throughout the day and night, interfering with bodily functions, exacerbate pain, limit rehabilitation, disrupt daily activities, and lower the overall quality of life.
About University of Miami
The University of Miami, https://welcome.miami.edu/, is a private research university with more than 17,000 students from around the world and is comprised of 12 schools and colleges serving undergraduate and graduate students in nearly 350 majors and programs. Established in 1925, UM is a major research university engaged in $324 million in research and sponsored program expenditures annually.
About The Miami Project to Cure Paralysis
The Miami Project, https://www.themiamiproject.org, a Center of Excellence at the University of Miami Miller School of Medicine, is now considered one of the premier research programs conducting cutting-edge discovery, translational and clinical investigations targeting traumatic spinal cord and brain injury, and other neurological disorders. The Miami Project’s international team of over 175 scientists, researchers, clinicians and support staff is dedicated to improving the quality of life and, ultimately, finding a cure for paralysis.
About Ikove Venture Partners
Ikove Venture Partners, www.ikovecapital.com, is a venture development company founded to pursue early-stage investments with an emphasis on technology commercialization. Through its proprietary Startup Nursery, in partnership with multiple U.S. research institutions, Ikove identifies and validates developing high-impact technologies, providing capital and commercialization resources to bridge the gap between R&D and VC funded rounds.
Media Contact: Jack Karabees: 1 (614) 602-1858, jkarabees@ulevohealth.com